Nektar to Webcast Presentation at UBS Global Healthcare Conference 2017 in New York

SAN FRANCISCO, May 15, 2017 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) announced today that its corporate presentation will be webcast at the upcoming UBS Global Healthcare Conference on Monday, May 22, 2017 at 1:30 p.m. Eastern time. 

The presentation will be accessible via a Webcast through a link posted on the Investors, Events Calendar section of the Nektar website: http://www.nektar.com. This Webcast will be available for replay for 14 days following the date of the presentation.

About Nektar

Nektar Therapeutics is a research-based development stage biopharmaceutical company whose mission is to discover and develop innovative medicines to address the unmet medical needs of patients. Our R&D pipeline of new investigational medicines includes treatments for cancer, auto-immune disease and chronic pain. We leverage Nektar's proprietary and proven chemistry platform in the discovery and design of our new therapeutic candidates. Nektar is headquartered in San Francisco, California, with additional operations in Huntsville, Alabama and Hyderabad, India. Further information about the company and its drug development programs and capabilities may be found online at http://www.nektar.com.

Contacts:

Jennifer Ruddock of Nektar Therapeutics
415-482-5585 

Jodi Sievers of Nektar Therapeutics
415-482-5593

SOURCE Nektar Therapeutics

Related Links

http://www.nektar.com